Impact of a modified needle tip geometry on penetration force as well as acceptability, preference, and perceived pain in subjects with diabetes

Journal of Diabetes Science and Technology

Volumn 6, Issue 2, 2012, Pages 328-335

  Hirsch, Laurence ^a   Gibney, Michael ^a   Berube, Julie ^a   Manocchio, John ^a  

^a BD Technologies   (United States)

Author keywords

Bevel; Injection; Needle tip; Pain; Pen needle

Indexed keywords

INSULIN; ANTIDIABETIC AGENT;

ADULT; AGED; ARTICLE; BEVEL NEEDLE; DIABETES MELLITUS; FEMALE; FORCE; GEOMETRY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NEEDLE; NOCICEPTION; NON INSULIN DEPENDENT DIABETES MELLITUS; PEN NEEDLE; SKIN PENETRATION; VISUAL ANALOG SCALE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; EQUIPMENT DESIGN; INSTRUMENTATION; MIDDLE AGED; MULTICENTER STUDY; PAIN; PAIN ASSESSMENT; PAIN THRESHOLD; PATHOPHYSIOLOGY; PATIENT PREFERENCE; PATIENT SATISFACTION; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION; UNITED STATES;

ADULT; AGED; DIABETES MELLITUS; DRUG DELIVERY SYSTEMS; EQUIPMENT DESIGN; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INJECTIONS, SUBCUTANEOUS; INSULIN; MALE; MIDDLE AGED; NEEDLES; NEW JERSEY; PAIN; PAIN MEASUREMENT; PAIN PERCEPTION; PAIN THRESHOLD; PATIENT PREFERENCE; PATIENT SATISFACTION; PROSPECTIVE STUDIES; QUESTIONNAIRES; YOUNG ADULT;

EID: 84864664032     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229681200600216     Document Type: Article

References (25)

1. Jørgensen JT. Improvement of patient convenience in treatment with growth hormone. J Pediatr Endocrinol. 1994;7(2):175-80. (Pubitemid 24144301)
2. Jørgensen JT, Romsing J, Rasmussen M, Møller-Sonnergaard J, Vang L, Musaeus L. Pain assessment of subcutaneous injections. Ann Pharmacother. 1996;30(7-8):729-32. (Pubitemid 26243913)
3. Egekvist H, Bjerring P, Arendt-Nielsen L. Pain and mechanical injury of skin following mechanical needle insertions. Eur J Pain. 1999;3(1):41-9. (Pubitemid 29166621)
4. Arendt-Nielsen L, Egekvist H, Bjerring P. Pain following controlled cutaneous insertion of needles with diferent diameters. Somatosens Mot Res. 2006;23(1-2):37-43. (Pubitemid 44114991)
5. Schwartz S, Hassman D, Shelmet J, Sievers R, Weinstein R, Liang J, Lyness W. A multicenter, open-label, randomized, two-period crossover trial comparing glycemic control, satisfaction, and preference with a 31 gauge x 6 mm needle versus a 29 gauge x 12.7 mm needle in obese patients with diabetes mellitus. Clin Ther. 2004;26(1):1663-78. (Pubitemid 39643027)
6. Kreugel G, Keers JC, Kerstens MN, Wolfenbuttel BHR. Randomized trial on the influence of the length of two insulin pen needles on glycemic control and patient preference in obese patients with diabetes. Diab Tech Ther. 2011;13(7):737-41.
7. Hirsch LJ, Gibney MA, Albanese J, Qu S, Kassler-Taub K, Klaf LJ, Bailey TS. Comparative glycemic control, safety, and patient ratings for a new 4 mm x 32 G insulin pen needle in adults with diabetes. Curr Med Res Opin. 2010;26(6):1531-41.
8. Chantelau E, Lee DM, Hemmann DM, Zipfel U, Echterhof S. What makes insulin injections painful? BMJ 1991;303(6793):26-7.
9. Vedrine L, Prais W, Laurent PE, Raynal-Olive C. Improving needle-point sharpness in prefillable syringes. Med Device Tech. 2003;14(4):32-5.
10. Jaber A, Bozzato GB, Vedrine L, Prais WA, Berube J, Laurent PE. A novel needle for subcutaneous injection of interferon beta-1a: effect on pain in volunteers and satisfaction in patients with multiple sclerosis. BMC Neurol. 2008;8:38. Doi:10.1186/1471-2377-8-38.
11. Powell CV, Kelly AM, Williams A. Determining the minimum clinically significant diference in visual analog pain score for children. Ann Emerg Med. 2001;37(1):28-31. (Pubitemid 32066336)
12. Bijur PE, Silver W, Gallagher EJ. Reliability of the visual analog scale for measurement of acute pain. Acad Emerg Med. 2001;8(12):1153-7. (Pubitemid 33108207)
13. Ross SA, Jamal R, Leiter LA, Josse R, Parkes J, Qu S, Kerestan S, Ginsberg B. Evaluation of 8 mm insulin pen needles in people with type 1 and type 2 diabetes. Pract Diab Intl. 1999;16(5):145-8. (Pubitemid 29410623)
14. Strauss K, Hannet I, McGonigle J, Parkes JL, Ginsberg B, Jamal R, Frid A. Ultra-short (5 mm) insulin needles: trial results and clinical recommendations. Pract Diab Intl. 1999;16(7):218-22. (Pubitemid 29533163)
15. http://www.iso.org/iso/home.htm. Accessed August 22, 2011.
16. Miyakoshi M, Kamoi K, Iwanaga M, Hoshiyama A, Yamada A. Comparison of patient's preference, pain perception, and usability between Micro Fine Plus® 31-gauge needle and microtapered Nanopass® 33-gauge needle for insulin therapy. J Diab Sci Technol. 2007;1(5):718-24.
17. Iwanaga M, Kanoi K. Patient perceptions of injection pain and anxiety: a comparison of NovoFine 32-gauge tip 6 mm and Micro Fine Plus 31-gauge 5 mm needles. Diab Tech Ther. 2009;11(2):81-6.
18. Fujimoto R, Okeda T, Nobuyuki A. Study on penetration pain of pen needles for insulin injection. Practice. 2009;26:95-9.
19. Hunt LM, Vlaenzuela MA, Pugh JA. NIDDM patients' fears and hopes about insulin therapy. The basis of patient reluctance. Diabetes Care. 1997;20(3):292-8. (Pubitemid 27098212)
20. Polonsky WH, Fisher L, Guzman S, Villa-Caballero L, Edelman SV. Psychological insulin resistance in patients with type 2 diabetes: the scope of the problem. Diabetes Care. 2005; 28(10):2543-5. (Pubitemid 41384310)
21. Vardar B, Kizilc S. Incidence of lipohypertrophy in diabetic patients and a study of influencing factors. Diab Res Clin Pract. 2007;77(2):231-6. (Pubitemid 46670424)
22. Richardson T, Kerr D. Skin-related complications of insulin therapy: epidemiology and emerging management strategies. Am J Clin Dermatol. 2003;4(10):661-7. (Pubitemid 37411982)
23. Strauss K, De Gols H, Hannet I, Partanen TM, Frid A. A pan-European epidemiologic study of insulin injection technique in patients with diabetes. Pract Diab Int. 2002;19(3):71-6.
24. Roper NA, Bilous RW. Resolution of lipohypertrophy following change of short-acting insulin to insulin lispro (Humalog). Diabet Med. 1998;15(12):1063-4. (Pubitemid 28539776)
25. Radermecker RP, Piérard GE, Scheen AJ. Lipodystrophy reactions to insulin: efects of continuous insulin infusion and new insulin analogs. Am J Clin Dermatol. 2007;8(1):21-8. (Pubitemid 46998560)